FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
ContraVir Pharmaceuticals Appoints Nathaniel Katz, M.D., Chairman of New Scientific Advisory Board
December 16, 2014
ContraVir Pharmaceuticals' CEO Issues Letter to Shareholders Highlighting Significant Progress
December 11, 2014
ContraVir Pharmaceuticals Initiates Pharmacokinetic Study of Lead Antiviral FV-100 for Treating Shingles
December 09, 2014
Synergy Pharmaceuticals Initiates First Phase 3 Clinical Trial of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation
December 18, 2014
Biotech Equities Scrutiny - Vanda Pharma, PDL BioPharma, Synergy Pharma, OPKO Health, and MiMedx
November 07, 2014
ContraVir Pharmaceuticals Selected to Present at Cavendish Global Health Impact Forum
November 05, 2014
Synergy Pharmaceuticals Announces Positive Results of SP-333 Phase 2 Trial in Patients with Opioid-Induced Constipation
November 19, 2014
Synergy Pharmaceuticals Reports Third Quarter 2014 Financial Results
November 10, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here